# Adaptive (ADPT) — Overview

ADPT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/adpt

## Price

Last close $25.58 on Oct 15, 2026. 52-week range $12.41 – $29.84.

## Company profile

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $308.1M |
| Revenue (quarter) | $71.6M |
| Revenue growth (year over year) | 21.53% |
| Gross profit (trailing twelve months) | $232.8M |
| Gross margin | 75.57% |
| Net income (trailing twelve months) | −$64.0M |
| Net income (quarter) | −$39.9M |
| Net income growth (year over year) | -56.06% |
| Net margin | -20.77% |
| Return on equity | -39.58% |
| EPS (trailing twelve months) | −$0.40 |
| Book value per share | $0.90 |
| P/E (trailing twelve months) | — |
| Price to book | 27.1 |
| Debt to assets | 76.48% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Adaptive (ADPT) profitable?

No. Adaptive reported a net loss of $64.0M over the trailing twelve months.

### How much revenue does Adaptive (ADPT) make?

Adaptive generated $308.1M in revenue over the trailing twelve months, up 21.53% year over year.

### How do I buy stock in Adaptive (ADPT)?

ADPT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).